Evaluation of fluorinated biphenyl ether pro-drug scaffolds employing the chemical-microbial approach

被引:6
作者
Hampton, Alex S. [1 ]
Mikulski, Lena [2 ]
Palmer-Brown, William [2 ]
Murphy, Cormac D. [2 ]
Sandford, Graham [1 ]
机构
[1] Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England
[2] Natl Univ Ireland Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland
关键词
Fluorine; Drug design; Phase; 1; metabolism; Ullmann condensation; Microbial model; HALF-LIFE; METABOLISM; CUNNINGHAMELLA; MICROSOMES;
D O I
10.1016/j.bmcl.2016.03.053
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Incorporation of fluorine in a drug can dramatically affect its metabolism and methods to assess the effect of fluorine substitution on drug metabolism are required for effective drug design. Employing a previously developed chemical-microbial method the metabolism of a series of fluorinated biphenyl ethers was determined. The substrates were synthesized via Ullmann-type condensation reactions between bromotoluene and fluorophenol. The ethers were incubated with the fungus Cunninghamella elegans, which oxidises xenobiotics in an analogous fashion to mammals, generating a number of hydroxylated biphenyl ethers and acids. The propensity of the fluorinated ring to be hydroxylated depended upon the position of the fluorine atom, and the oxidation of the methyl group was observed when it was meta to the oxygen. The experiments demonstrate the applicability of the method to rapidly determine the effect of fluorine substitution on CYP-catalysed biotransformation of pro-drug molecules. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2255 / 2258
页数:4
相关论文
共 14 条
[1]   Biotransformation of fluorobiphenyl by Cunninghamella elegans [J].
Amadio, Jessica ;
Murphy, Cormac D. .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2010, 86 (01) :345-351
[2]   Cunninghamella - A microbial model for drug metabolism studies - A review [J].
Asha, Sepuri ;
Vidyavathi, Maravajhala .
BIOTECHNOLOGY ADVANCES, 2009, 27 (01) :16-29
[3]   Fluorine in medicinal chemistry [J].
Böhm, HJ ;
Banner, D ;
Bendels, S ;
Kansy, M ;
Kuhn, B ;
Müller, K ;
Obst-Sander, U ;
Stahl, M .
CHEMBIOCHEM, 2004, 5 (05) :637-643
[4]   A convenient chemical-microbial method for developing fluorinated pharmaceuticals [J].
Bright, Tara V. ;
Dalton, Fay ;
Elder, Victoria L. ;
Murphy, Cormac D. ;
O'Connor, Neil K. ;
Sandford, Graham .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2013, 11 (07) :1135-1142
[5]   Introduction: Human Metabolites in Safety Testing (MIST) Issue [J].
Guengerich, F. Peter .
CHEMICAL RESEARCH IN TOXICOLOGY, 2009, 22 (02) :237-238
[6]   Methods for predicting human drug metabolism [J].
Jolivette, Larry J. ;
Ekins, Sean .
ADVANCES IN CLINICAL CHEMISTRY, VOL 43, 2007, 43 :131-176
[7]   Recent advances in fluorination techniques and their anticipated impact on drug metabolism and toxicity [J].
Murphy, Cormac D. ;
Sandford, Graham .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (04) :589-599
[8]   Drug metabolism in microorganisms [J].
Murphy, Cormac D. .
BIOTECHNOLOGY LETTERS, 2015, 37 (01) :19-28
[9]  
Obach RS, 1999, DRUG METAB DISPOS, V27, P1350
[10]   CONVERSION OF PHENOL DERIVATIVES TO HYDROXYLATED PRODUCTS BY PHENOL HYDROXYLASE FROM TRICHOSPORON-CUTANEUM - A COMPARISON OF REGIOSELECTIVITY AND RATE OF CONVERSION WITH CALCULATED MOLECULAR-ORBITAL SUBSTRATE CHARACTERISTICS [J].
PEELEN, S ;
RIETJENS, IMCM ;
BOERSMA, MG ;
VERVOORT, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 227 (1-2) :284-291